guanidinopropylsuccinic acid has been researched along with clofibrate in 1 studies
*Clofibrate: A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) [MeSH]
*Clofibrate: A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) [MeSH]
| Studies (guanidinopropylsuccinic acid) | Trials (guanidinopropylsuccinic acid) | Recent Studies (post-2010) (guanidinopropylsuccinic acid) | Studies (clofibrate) | Trials (clofibrate) | Recent Studies (post-2010) (clofibrate) |
|---|---|---|---|---|---|
| 5 | 0 | 3 | 3,859 | 314 | 131 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Liu, Y; Qian, Y; Wang, Y; Yin, Z | 1 |
1 other study(ies) available for guanidinopropylsuccinic acid and clofibrate
| Article | Year |
|---|---|
Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
Topics: Breast; Breast Neoplasms; Clofibrate; Female; Humans; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Tumor Microenvironment | 2023 |